A detailed history of Rhenman & Partners Asset Management Ab transactions in Glaukos Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 111,000 shares of GKOS stock, worth $16.7 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
111,000
Previous 50,000 122.0%
Holding current value
$16.7 Million
Previous $5.92 Million 144.4%
% of portfolio
1.2%
Previous 0.58%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$113.62 - $135.39 $6.93 Million - $8.26 Million
61,000 Added 122.0%
111,000 $14.5 Million
Q2 2024

Aug 13, 2024

BUY
$89.48 - $118.35 $2.06 Million - $2.72 Million
23,000 Added 85.19%
50,000 $5.92 Million
Q1 2024

May 14, 2024

SELL
$76.4 - $96.33 $7.11 Million - $8.96 Million
-93,000 Reduced 77.5%
27,000 $2.55 Million
Q4 2023

Feb 13, 2024

BUY
$59.53 - $85.11 $2.8 Million - $4 Million
47,000 Added 64.38%
120,000 $9.54 Million
Q3 2023

Nov 13, 2023

SELL
$69.23 - $79.09 $17.1 Million - $19.5 Million
-247,000 Reduced 77.19%
73,000 $5.49 Million
Q3 2023

Nov 09, 2023

BUY
$69.23 - $79.09 $15.6 Million - $17.8 Million
225,000 Added 236.84%
320,000 $24.1 Million
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $136,320 - $213,629
3,000 Added 3.26%
95,000 $6.76 Million
Q1 2023

May 11, 2023

BUY
$43.88 - $52.48 $307,160 - $367,360
7,000 Added 8.24%
92,000 $4.61 Million
Q3 2022

Nov 14, 2022

SELL
$46.84 - $58.49 $233,778 - $291,923
-4,991 Reduced 5.55%
85,000 $4.77 Million
Q2 2022

Aug 12, 2022

SELL
$34.86 - $63.77 $533,358 - $975,681
-15,300 Reduced 14.53%
89,991 $4.09 Million
Q1 2022

May 13, 2022

SELL
$44.33 - $57.82 $3.09 Million - $4.03 Million
-69,709 Reduced 39.83%
105,291 $6.09 Million
Q4 2021

Feb 11, 2022

BUY
$40.27 - $56.99 $1.01 Million - $1.42 Million
25,000 Added 16.67%
175,000 $8.02 Million
Q3 2021

Nov 12, 2021

BUY
$47.43 - $84.23 $5.45 Million - $9.69 Million
115,000 Added 328.57%
150,000 $7.23 Million
Q1 2021

May 14, 2021

SELL
$70.43 - $97.42 $6.34 Million - $8.77 Million
-90,000 Reduced 72.0%
35,000 $2.94 Million
Q4 2020

Jan 19, 2021

SELL
$48.9 - $75.26 $733,500 - $1.13 Million
-15,000 Reduced 10.71%
125,000 $9.41 Million
Q2 2020

Jul 16, 2020

SELL
$28.78 - $46.83 $719,500 - $1.17 Million
-25,000 Reduced 15.15%
140,000 $5.38 Million
Q1 2020

Apr 16, 2020

SELL
$25.53 - $70.14 $1.79 Million - $4.91 Million
-70,000 Reduced 29.79%
165,000 $5.09 Million
Q4 2019

Jan 17, 2020

BUY
$54.18 - $65.64 $292,572 - $354,456
5,400 Added 2.35%
235,000 $12.8 Million
Q3 2019

Oct 16, 2019

SELL
$58.58 - $83.91 $369,698 - $529,556
-6,311 Reduced 2.68%
229,600 $14.4 Million
Q2 2019

Jul 22, 2019

BUY
$63.59 - $78.71 $21,111 - $26,131
332 Added 0.14%
235,911 $17.8 Million
Q1 2019

Apr 11, 2019

SELL
$50.75 - $80.54 $253,750 - $402,700
-5,000 Reduced 2.08%
235,579 $18.5 Million
Q4 2018

Feb 05, 2019

SELL
$52.18 - $67.93 $2.12 Million - $2.76 Million
-40,700 Reduced 14.47%
240,579 $13.5 Million
Q3 2018

Oct 03, 2018

SELL
$38.13 - $68.37 $3 Million - $5.38 Million
-78,721 Reduced 21.87%
281,279 $18.3 Million
Q2 2018

Jul 20, 2018

SELL
$27.62 - $44.51 $3.96 Million - $6.38 Million
-143,400 Reduced 28.49%
360,000 $14.6 Million
Q1 2018

Apr 11, 2018

SELL
$26.05 - $34.5 $2.74 Million - $3.62 Million
-105,000 Reduced 17.26%
503,400 $15.5 Million
Q4 2017

Jan 19, 2018

SELL
$24.5 - $36.01 $965,202 - $1.42 Million
-39,396 Reduced 6.08%
608,400 $15.6 Million
Q3 2017

Oct 13, 2017

BUY
$31.26 - $42.03 $20.3 Million - $27.2 Million
647,796
647,796 $21.4 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.